Drug abuse is an important route of exposure for HIV-1. Both methamphetamine and lentiviral infections cause neurotoxicity and immunosuppression. However, the interactions between HIV-1 and methamphetamine in neurologic disease progression remain unclear. Part of the reason for this lack of information is that gathering data in people is particularly difficult, given the populations that engage in drug abuse. Additionally, invasive investigative measures are not possible in people. Thus, there is a pressing need for appropriate animal models to examine the role of methamphetamine on lentivirus disease progression, particularly the CNS form of the disease. We have now developed the feline/FIV model as a legitimate system for the study lf lentivirus induced neurologic disease. We have now developed the feline/FIV model as a legitimate system for the study of lentivirus induced neurologic disease. Not only does FIV produce a disease that is very similar to human AIDS, but it is also similar to HIV at both the molecular and biochemical levels. Numerous parameters have been established to monitor the effects ov irus injection on the CNS. We now want to apply this model to understand the potential interactions that methamphetamine may have with the neurological form of this lentivirus induced disease. In this proposed project. we plan to examine the in vitro effects of methamphetamine on the replication and transcriptional efficiency of FIV as well as investigate the outcome of methamphetamine schedule on FIV disease progression, by comparing the effects of administering methamphetamine in a single injection, multiple acute injections, and chronic administration. In order to better understand the effects of drug abuse on lentiviral disease progression, it is critical to have a model system that is pertinent, yet amenable to thorough testing and evaluation. As the smallest model for the study of natural lentivirus infections, the FIV/cat system provides the most economical and useful system for evaluating the effects of methamphetamine on lentivirus induced disease. The long-term objective of this proposal is to fully develop the FIV/cat system into a predictive animal model for assessing the effects of illicit drug use on the neurological form of this lentivirus induced disease.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Program Projects (P01)
Project #
5P01DA012444-02
Application #
6464632
Study Section
Special Emphasis Panel (ZDA1)
Project Start
2001-06-15
Project End
2002-05-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2001
Total Cost
$350,741
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Huitron-Resendiz, Salvador; Henriksen, Steven J; Barr, Margaret C et al. (2010) Methamphetamine and lentivirus interactions: reciprocal enhancement of central nervous system disease. J Neurovirol 16:268-78
Sanchez-Alavez, Manuel; Conti, Bruno; Moroncini, Gianluca et al. (2007) Contributions of neuronal prion protein on sleep recovery and stress response following sleep deprivation. Brain Res 1158:71-80
Persidsky, Yuri; Fox, Howard (2007) Battle of animal models. J Neuroimmune Pharmacol 2:171-7
Milner, Richard; Campbell, Iain L (2006) Increased expression of the beta4 and alpha5 integrin subunits in cerebral blood vessels of transgenic mice chronically producing the pro-inflammatory cytokines IL-6 or IFN-alpha in the central nervous system. Mol Cell Neurosci 33:429-40
Criado, Jose R; Sanchez-Alavez, Manuel; Conti, Bruno et al. (2005) Mice devoid of prion protein have cognitive deficits that are rescued by reconstitution of PrP in neurons. Neurobiol Dis 19:255-65
Madden, Lisa J; Flynn, Claudia T; Zandonatti, Michelle A et al. (2005) Modeling human methamphetamine exposure in nonhuman primates: chronic dosing in the rhesus macaque leads to behavioral and physiological abnormalities. Neuropsychopharmacology 30:350-9
Balosso, Silvia; Ravizza, Teresa; Perego, Carlo et al. (2005) Tumor necrosis factor-alpha inhibits seizures in mice via p75 receptors. Ann Neurol 57:804-12
Huitron-Resendiz, Salvador; Kristensen, Morten P; Sanchez-Alavez, Manuel et al. (2005) Urotensin II modulates rapid eye movement sleep through activation of brainstem cholinergic neurons. J Neurosci 25:5465-74
Vlkolinsky, Roman; Siggins, George R; Campbell, Iain L et al. (2004) Acute exposure to CXC chemokine ligand 10, but not its chronic astroglial production, alters synaptic plasticity in mouse hippocampal slices. J Neuroimmunol 150:37-47
Crocker, Stephen J; Pagenstecher, Axel; Campbell, Iain L (2004) The TIMPs tango with MMPs and more in the central nervous system. J Neurosci Res 75:1-11

Showing the most recent 10 out of 26 publications